Ergebnis der Suchanfrage nach Peter-Ording

GEA Group Aktiengesellschaft

3

GEA helps Nestlé cut steam consumption by 75% at its new infant formula plant

GEA Group Aktiengesellschaft

Pioneering project: GEA launches custom AI chatbot based on Microsoft Azure OpenAI Service

STADA Arzneimittel AG

3

Press release: STADA further improves Sustainability ranking; rates among top 6% of pharma players globally

GEA Group Aktiengesellschaft

3

New fryingsolution from GEA sets new standards

GEA Group Aktiengesellschaft

3

GEA expands LoTo valve locking during maintenance of aseptic processes

GEA Group Aktiengesellschaft

4

GEA helps breweries to harness sustainability KPIs through AI

ecomBETZ PR GmbH

EMO 2023 – DVS TECHNOLOGY GROUP: One group, one drive, one desig

Öko-Institut e.V.

Factsheets released on different project types in the carbon market

Joint press release by Oeko-Institut, CCQI and Foundation Development and Climate Alliance Berlin, 12 September 2023 Factsheets released on different project types in the carbon market To contribute to achieving the Paris Climate Agreement and the Sustainable Development Goals, carbon credits in the voluntary carbon market need to be of high quality. ...

BBS automotive GmbH

5

BBS CI-R Unlimited: Available with unique adapter system for all BMW models

STADA Arzneimittel AG

2

Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty

STADA Arzneimittel AG

Press release : STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from Sanofi

Leipzig Tourismus und Marketing GmbH

5

Oper Leipzig Presents 12 Premieres and the Ballet Festival

STADA Arzneimittel AG

Press release: STADA appoints Christos Gallis as Head of Eastern Europe

nova-Institut GmbH

Invitation to coverage and press conference – Renewable Materials Conference 2023, Siegburg near Cologne, Germany

STADA Arzneimittel AG

Press release: STADA and Xbrane launch ranibizumab to support patient access in Europe

STADA and Xbrane launch ranibizumab to support patient access in Europe - Ranibizumab biosimilar is being launched in major European markets - Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane, marking Xbrane’s first commercial launch and ...

nova-Institut GmbH

5

From Emission-made Shoes to Jet Fuels – Smart Innovations Make CO₂ the Feedstock of the Future

STADA Arzneimittel AG

Press release: STADA sustains strong momentum with double-digit sales and profit growth in 2022

EUROEXPO Messe- und Kongress GmbH

LogiMAT 2023 | Intralogistics Expertise on Three Stages

Fördergesellschaft IZB mbH

Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris

Deutsche Hospitality

2

Focus on the essentials: Zleep Hotels comes to Berlin Airport

Deutsche Hospitality

5

Deutsche Hospitality appoints new management positions

STADA Arzneimittel AG

Press release: STADA appoints Boris Döbler as Chief Financial Officer

STADA Arzneimittel AG

3

Press release: STADA ranks among top 10% of pharma firms on sustainability

Rosberg X Racing

3

Rosberg X Racing and Extreme E join forces with Allianz, Life Terra and the MEDSEA Foundation to restore wildfire-affected area in Sardinia

Aurubis AG

Press Release: Aurubis AG: Collaboration with Anglo American plc for sustainably sourced and supplied copper

STADA Arzneimittel AG

Press release: Stéphane Jacqmin joins STADA from Sanofi and becomes Head of Emerging Markets

Deutsche Hospitality

Zleep Hotel becomes first hotel partner of the innovative center in Horsens, Denmark

BBS automotive GmbH

4

World Wheel Award 2023: The light-alloy wheel manufacturer BBS from Germany applies with the RT Unlimited (RT-U) wheel

STADA Arzneimittel AG

Press release: STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis®

STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis® - European Commission grants pan-EU marketing authorization for Ximluci® biosimilar referencing Lucentis® (ranibizumab) - Paves way for European ...

Aurubis AG

6

Press Release: Decarbonizing production: Aurubis begins test series for the use of blue ammonia in copper rod production